Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib StudyJ. Clin. Oncol 2020 Feb 14;[EPub Ahead of Print], S Modi, H Park, RK Murthy, H Iwata, K Tamura, J Tsurutani, A Moreno-Aspitia, T Doi, Y Sagara, C Redfern, IE Krop, C Lee, Y Fujisaki, M Sugihara, L Zhang, J Shahidi, S Takahashi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.